Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Marcus Westerberg"'
Publikováno v:
PLoS ONE, Vol 19, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/bb9468a6470642309518fe9436f0c53a
Autor:
Eugenio Ventimiglia, Anna Bill-Axelson, Jan Adolfsson, Markus Aly, Martin Eklund, Marcus Westerberg, Pär Stattin, Hans Garmo
Publikováno v:
European Urology Open Science, Vol 44, Iss , Pp 46-51 (2022)
Background: Little is known about disease trajectories for men with castration-resistant prostate cancer (CRPC). Objective: To create a state transition model that estimates time spent in the CRPC state and its outcomes. Design, setting, and particip
Externí odkaz:
https://doaj.org/article/85d3a094259c49b2bb543a344ae02efc
Autor:
Magdalena Lycken, Oskar Bergengren, Linda Drevin, Hans Garmo, Marcus Westerberg, Elin Axén, Johan Stranne, Lars Holmberg, Anna Bill-Axelson
Publikováno v:
European Urology Open Science, Vol 41, Iss , Pp 81-87 (2022)
Background: Attempts to reduce prostate cancer (PC) mortality require an understanding of temporal changes in the characteristics of men with lethal PC. Objective: To describe the diagnostic characteristics of and time trends for a nationwide populat
Externí odkaz:
https://doaj.org/article/141e59a3db684f1991502da8c1034c20
Autor:
Yashar Khoshkar, Marcus Westerberg, Jan Adolfsson, Anna Bill‐Axelson, Henrik Olsson, Martin Eklund, Olof Akre, Hans Garmo, Markus Aly
Publikováno v:
BJUI Compass, Vol 3, Iss 2, Pp 173-183 (2022)
Abstract Objectives The objective of this study is to find clinical variables that predict the prognosis for men with castration‐resistant prostate cancer (CRPC) in a Swedish real‐life CRPC cohort, including a risk group classification to clarify
Externí odkaz:
https://doaj.org/article/ffef690841a74629b9214454386fd3cc
Autor:
Andri Wilberg Orrason, Marcus Westerberg, Peter Albertsen, Johan Styrke, David Robinson, Hans Garmo, Pär Stattin
Publikováno v:
PLoS ONE, Vol 17, Iss 11, p e0277784 (2022)
The main aim of the study was to determine the impact of diagnostic activity and life expectancy on the lifetime risk of a prostate cancer diagnosis. We used a state transition simulation model based on Swedish population-based data to simulate life
Externí odkaz:
https://doaj.org/article/2ad4b3c7ca05497797e8f90e36342c53
Autor:
Frederik B Thomsen, Marcus Westerberg, Hans Garmo, David Robinson, Lars Holmberg, Hans David Ulmert, Pär Stattin
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0228447 (2020)
The objective was to investigate the proportion of men with metastatic prostate cancer in groups defined by T stage, Gleason Grade Group (GGG) and serum levels of prostate-specific antigen (PSA) and if PSA can be used to rule in metastatic prostate c
Externí odkaz:
https://doaj.org/article/a866516e42c04d87980c162abf63c5bb
Autor:
Marcus Westerberg, Kerri Beckmann, Rolf Gedeborg, Sandra Irenaeus, Lars Holmberg, Hans Garmo, Pär Stattin
Publikováno v:
Journal of Clinical Epidemiology. 155:22-30
Refereed/Peer-reviewed Objectives: To study how handling missing data on M stage in a clinical cancer register affects estimates of incidence of metastatic prostate cancer. Study Design and Setting: Estimates of age-standardized incidence of metastat
Autor:
Marcus Westerberg
Publikováno v:
Statistical Methods in Medical Research. 32:806-819
We consider the analysis of longitudinal data of multiple types of events where some of the events are observed on a coarser level (e.g. grouped) at some time points during the follow-up, for example, when certain events, such as disease progression,
Autor:
Tiago M. Bonde, Marcus Westerberg, Markus Aly, Martin Eklund, Jan Adolfsson, Anna Bill-Axelson, Hans Garmo, Pär Stattin, David Robinson
Publikováno v:
Scandinavian Journal of Urology. 56:169-175
Objectives: To predict castration-resistant prostate cancer (CRPC) and prostate cancer (Pca) death by use of clinical variables at Pca diagnosis and PSA levels after start of gonadotropin-releasing hormone agonists (GnRH) in men with non-metastatic c
Autor:
Jan Adolfsson, Henrik Olsson, Hans Garmo, Markus Aly, Marcus Westerberg, Olof Akre, Yashar Khoshkar, Anna Bill-Axelson, Martin Eklund
Publikováno v:
BJUI Compass, Vol 3, Iss 2, Pp 173-183 (2022)
Objectives The objective of this study is to find clinical variables that predict the prognosis for men with castration‐resistant prostate cancer (CRPC) in a Swedish real‐life CRPC cohort, including a risk group classification to clarify the risk